
Thursday, October 03, 2024 1:34:51 PM
Recent ELYM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2025 09:15:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2025 09:15:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 01:08:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2024 09:15:03 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/25/2024 05:15:09 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 02:29:34 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/12/2024 09:51:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 11:08:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 08:15:00 PM
- Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. • GlobeNewswire Inc. • 10/02/2024 01:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/21/2024 01:53:19 AM
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit • GlobeNewswire Inc. • 09/11/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 09:21:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:47:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 11:07:00 AM
- Eliem Therapeutics Announces Additions to its Leadership Team • GlobeNewswire Inc. • 08/26/2024 11:00:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/16/2024 08:23:26 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/14/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 10:10:47 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 10:06:54 AM
- Eliem Therapeutics Reports Second Quarter Financial Results • GlobeNewswire Inc. • 08/14/2024 10:05:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM